APA-referens

Vogelmeier, C., Zhong, N., Humphries, M. J., Mezzi, K., Fogel, R., Bader, G., . . . Banerji, D. (2016). Indacaterol/glycopyrronium in symptomatic patients with COPD (GOLD B and GOLD D) versus salmeterol/fluticasone: ILLUMINATE/LANTERN pooled analysis. Int J Chron Obstruct Pulmon Dis.

Chicago-stil citat

Vogelmeier, Claus, Nanshan Zhong, Michael J. Humphries, Karen Mezzi, Robert Fogel, Giovanni Bader, Francesco Patalano, och Donald Banerji. "Indacaterol/glycopyrronium in Symptomatic Patients With COPD (GOLD B and GOLD D) Versus Salmeterol/fluticasone: ILLUMINATE/LANTERN Pooled Analysis." Int J Chron Obstruct Pulmon Dis 2016.

MLA-referens

Vogelmeier, Claus, et al. "Indacaterol/glycopyrronium in Symptomatic Patients With COPD (GOLD B and GOLD D) Versus Salmeterol/fluticasone: ILLUMINATE/LANTERN Pooled Analysis." Int J Chron Obstruct Pulmon Dis 2016.

Varning: dessa hänvisningar är inte alltid fullständigt riktiga.